Clinical Trial: A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586514) titled 'A Study to Assess Safety, Tolerability and Exposure of 4ET1103 in Healthy Human Volunteers' on April 22.

Brief Summary: This study will dose healthy human volunteers with either active drug (4ET1103) or placebo. Each study subject will receive a single dose of either active drug or placebo, and will then be monitored for safety, tolerability and exposure of active drug.

Study Start Date: April 18, 2025

Study Type: INTERVENTIONAL

Condition: Neuropathic Pain

Intervention: DRUG: Treatment for neuropathic pain

MNK inhibitor for treatment of neuropathic pain

DRUG: placebo

placebo for MNK inhibitor

Recruitment Status: COMPLETED ...